RPRX

26.43

0.11% 0.03

Dopo l'orario di chiusura: 26.43

Royalty Pharma Plc (RPRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$26.40

Aprire:

$26.38

Volume 24 ore:

2.40M

Relative Volume:

1.08

Capitalizzazione di mercato:

$11.74B

Reddito:

$2.24B

Utile/perdita netta:

$673.24M

Rapporto P/E:

234.93

EPS:

0.1125

Flusso di cassa netto:

$2.67B

1 W Prestazione:

+2.84%

1M Prestazione:

-3.43%

6M Prestazione:

-3.29%

1 anno Prestazione:

-2.76%

Intervallo 1D:

$26.33

$26.63

Intervallo di 1 settimana:

$25.47

$26.66

Portata 52W:

$25.10

$31.66

Royalty Pharma Plc Stock (RPRX) Company Profile

Nome

Royalty Pharma Plc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

(212) 883-0200

Indirizzo

110 EAST 59TH STREET, NEW YORK, NY

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

RPRX's Discussions on Twitter

Confronta RPRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RPRX	26.43	11.74B	2.24B	673.24M	2.67B	0.1125
VRTX	450.97	116.14B	10.63B	-479.80M	-1.35B	13.33
REGN	738.00	81.10B	13.85B	4.65B	3.32B	35.06
ARGX	605.92	36.23B	1.86B	-40.29M	-1.28B	-4.16
ALNY	244.89	31.59B	2.09B	-332.26M	16.06M	-4.14
BNTX	113.13	27.12B	3.30B	-501.07M	1.03B	11.54

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-06-03	Downgrade	UBS	Buy → Neutral
2022-06-14	Ripresa	UBS	Buy
2022-05-13	Iniziato	Scotiabank	Sector Outperform
2022-04-27	Iniziato	Goldman	Buy
2022-04-14	Aggiornamento	JP Morgan	Neutral → Overweight
2022-04-06	Ripresa	Morgan Stanley	Overweight
2021-10-29	Aggiornamento	Citigroup	Neutral → Buy
2021-07-30	Iniziato	Tigress Financial	Buy
2020-11-09	Aggiornamento	UBS	Neutral → Buy
2020-07-14	Iniziato	Evercore ISI	In-line
2020-07-13	Iniziato	BofA Securities	Buy
2020-07-13	Iniziato	Citigroup	Neutral
2020-07-13	Iniziato	Cowen	Outperform
2020-07-13	Iniziato	Goldman	Neutral
2020-07-13	Iniziato	JP Morgan	Neutral
2020-07-13	Iniziato	Morgan Stanley	Equal-Weight
2020-07-13	Iniziato	SunTrust	Buy
2020-07-13	Iniziato	UBS	Neutral

Mostra tutto

Royalty Pharma Plc Borsa (RPRX) Ultime notizie

05:08 AM

BNP PARIBAS ASSET MANAGEMENT Holding S.A. Raises Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

05:08 AM

04:38 AM

Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

04:38 AM

Nov 22, 2024

Thrivent Financial for Lutherans Purchases 168,905 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 22, 2024

Nov 21, 2024

Overbrook Management Corp Sells 59,504 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 21, 2024

Nov 19, 2024

Royalty Pharma (NASDAQ:RPRX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Nov 19, 2024

Victory Capital Management Inc. Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 19, 2024

RPRXRoyalty Pharma plc Latest Stock News & Market Updates - StockTitan

Nov 19, 2024

Nov 17, 2024

Amalgamated Bank Sells 48,057 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + - Seeking Alpha

Nov 16, 2024

Nov 15, 2024

Royalty Pharma stock hits 52-week low at $25.2 amid market shifts - Investing.com India

Nov 15, 2024

Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week LowTime to Sell? - MarketBeat

Nov 15, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by Simplify Asset Management Inc. - MarketBeat

Nov 15, 2024

Nov 14, 2024

(RPRX) Technical Data - Stock Traders Daily

Nov 14, 2024

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare - The Manila Times

Nov 14, 2024

Royalty Pharma Awards Inaugural Healthcare Prize to Michael Milken for Cancer Research Impact | RPRX Stock News - StockTitan

Nov 14, 2024

3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a Decade - The Motley Fool

Nov 14, 2024

Nov 13, 2024

Ex-Dividend Reminder: Cencora, Royalty Pharma and Brookline Bancorp - Nasdaq

Nov 13, 2024

Solid Earnings May Not Tell The Whole Story For Royalty Pharma (NASDAQ:RPRX) - Simply Wall St

Nov 13, 2024

Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues - Yahoo Finance

Nov 13, 2024

Syndax shares slide despite pivotal trial success - The Pharma Letter

Nov 13, 2024

Nov 12, 2024

New South Capital Management Inc. Has $69.77 Million Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 12, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 12, 2024

Los Angeles Capital Management LLC Lowers Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Van ECK Associates Corp Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 11, 2024

Nov 10, 2024

Royalty Pharma Q3 2024 Earnings Preview - MSN

Nov 10, 2024

Summit Global Investments Purchases New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 10, 2024

Nov 09, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Executive Wealth Management LLC - MarketBeat

Nov 09, 2024

Royalty Pharma Stock: Massive Opportunity Ahead (NASDAQ:RPRX) - Seeking Alpha

Nov 09, 2024

Nov 08, 2024

Morgan Stanley's Strategic Reduction in Royalty Pharma PLC Holdi - GuruFocus.com

Nov 08, 2024

Nov 07, 2024

Royalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million - The Manila Times

Nov 07, 2024